SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006991
Filing Date
2015-08-11
Accepted
2015-08-11 16:01:44
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-10q_20150630.htm 10-Q 1686916
2 EX-10.1 akba-ex101_270.htm EX-10.1 313526
3 EX-31.1 akba-ex311_9.htm EX-31.1 15742
4 EX-31.2 akba-ex312_6.htm EX-31.2 15574
5 EX-32.1 akba-ex321_7.htm EX-32.1 12895
  Complete submission text file 0001564590-15-006991.txt   7129944

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akba-20150630.xml EX-101.INS 1766073
7 XBRL TAXONOMY EXTENSION SCHEMA akba-20150630.xsd EX-101.SCH 35350
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20150630_cal.xml EX-101.CAL 44542
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20150630_def.xml EX-101.DEF 94405
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20150630_lab.xml EX-101.LAB 281779
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20150630_pre.xml EX-101.PRE 223743
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 151043891
SIC: 2834 Pharmaceutical Preparations